News

British Academy elects 12 Cambridge researchers to Fellowship in 2025

30 July 2025

Twelve academics from the University of Cambridge have been made Fellows of the prestigious British Academy for the humanities and social science They are among 92 distinguished scholars to be elected to the fellowship in recognition of their work in fields ranging from medieval history to international relations. It...

Cambridge and AstraZeneca: a decade of partnership and impact

30 July 2025

The University of Cambridge and AstraZeneca have a long history of scientific collaboration. In 2013, AstraZeneca’s decision to move its global headquarters and new strategic R&D centre to Cambridge started a new chapter of partnership. AstraZeneca chose Cambridge – the largest life science cluster in Europe – for its...

Cambridge part of new Global Talent Fund plan to attract world’s best R&D to UK

30 July 2025

Cambridge University has been selected as a partner in a key Government initiative to attract more of the world’s best research talent to the UK. Because of its track record in recruiting and supporting top international researchers, the University will get a share of the new £54 million Global Talent Fund , along with 12...

Mice are vital in the search for effective new dementia treatments

30 July 2025

Cambridge researchers are leading drug discovery to develop safer, more effective treatments for the millions of people affected by Alzheimer’s and other neurodegenerative diseases. According to Alzheimer’s Research UK, if nothing changes one in two of us will be affected by dementia in our lifetime, either by caring for...

DNA sequencing method lifts ‘veil’ from genome black box

24 January 2023

Many life-saving drugs directly interact with DNA to treat diseases such as cancer, but scientists have struggled to detect how and why they work – until now. In a paper published in the journal Nature Biotechnology , University of Cambridge researchers have outlined a new DNA sequencing method that can detect where and...

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

4 January 2023

Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients. Tumours are incredibly complex, made up of many different types of tumour cells – and some of...

Blood thinning drug to treat recovery from severe COVID-19 is not effective

30 November 2022

A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke’s Hospital and the University of Cambridge has found. This finding is important because it will prevent unnecessary harm...

Clinical trial for new stem cell-based treatment for Parkinson’s disease given go ahead

9 November 2022

Cambridge researchers will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease. This could transform the way we treat Parkinson’s disease Roger Barker The Swedish Medical Products Agency has granted approval for the trial...

Set up reserve lab capacity now for faster response to next pandemic, say researchers

12 October 2022

Researchers say a ‘human bottleneck’, due to historical cuts in public health funding, delayed the UK’s scale-up of COVID-19 testing in the early stages of the country’s pandemic response. A pandemic like COVID-19 is guaranteed to happen again at some point. Jordan Skittrall The researchers, who were on the front line of...

Cambridge researchers elected as members of European Molecular Biology Organisation

7 September 2022

Five Cambridge researchers join the community of more than 1,900 leading life scientists in Europe and beyond today as the European Molecular Biology Organisation (EMBO) announces its newly-elected Members. EMBO Members are recognised for their outstanding achievements in the life sciences. The newly elected members reside...

British Academy elects 12 Cambridge researchers to Fellowship in 2025

Cambridge and AstraZeneca: a decade of partnership and impact

Cambridge part of new Global Talent Fund plan to attract world’s best R&D to UK

Mice are vital in the search for effective new dementia treatments

DNA sequencing method lifts ‘veil’ from genome black box

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

Blood thinning drug to treat recovery from severe COVID-19 is not effective

Clinical trial for new stem cell-based treatment for Parkinson’s disease given go ahead

Set up reserve lab capacity now for faster response to next pandemic, say researchers

Cambridge researchers elected as members of European Molecular Biology Organisation

Study at Cambridge

About the University

Research at Cambridge